Invention Grant
- Patent Title: Crystalline forms of a triazolopyrimidine compound
-
Application No.: US17371399Application Date: 2021-07-09
-
Publication No.: US11548897B2Publication Date: 2023-01-10
- Inventor: Ying Huang , Bo Liu , Liang Mao , Long Wang , Liladhar Murlidhar Waykole , Lijun Zhang
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Daniel E. Raymond
- Priority: WOPCT/CN2016/086350 20160620
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P35/00 ; A61P35/02 ; A61K31/519
Abstract:
Provided herein are crystalline forms of a triazolopyrimidine compound, which is useful for treating a PRC2-mediated disease or disorder.
Public/Granted literature
- US20210340152A1 CRYSTALLINE FORMS OF A TRIAZOLOPYRIMIDINE COMPOUND Public/Granted day:2021-11-04
Information query
